The Extra Year That Made All the Difference 

After 25 years working in oncology, Jon Travers understood the impact cancer can have on patients and their families. Throughout his career, he had been driven by the possibility of helping bring new treatments to the people who need them most. 

But around ten years ago, that mission became deeply personal. 

When Jon’s mother was diagnosed with a recurrence of melanoma, it was the third time she had faced cancer. Nearly two decades after her previous diagnosis, the disease had returned, and the outlook was poor. Like many families facing a cancer diagnosis, they were confronted with the possibility that they might have very little time left together. 

An opportunity to access an innovative treatment through an expanded access program changed the course of that journey. 

The treatment gave Jon’s mother an additional year of life and, most importantly, an additional year of quality life. It gave the family time to be together, create memories, and share moments they might otherwise never have had. 

Witnessing that impact firsthand changed the way Jon viewed his work. What had once been a professional commitment to innovation became a personal understanding of what new medicines can mean for patients and the people who love them. 

Today, as Senior Director, External Innovation, that experience continues to shape the way he approaches every opportunity. Beyond the science and the data, he sees the potential human impact behind every innovation Ipsen explores. 

For Jon, the value of a new medicine is measured not only by clinical outcomes, but also by the time it can give patients and families, and the moments that time can make possible. 

His story is a reminder that innovation can create something precious: more time together. Sometimes, even one extra year can make all the difference.